Table 1:
Demographic, clinical, and deep brain stimulation information for the patient group
| Characteristic | DBS Programming Information |
||||
|---|---|---|---|---|---|
| Left | Right | ||||
| Age at surgery (yr) | 42.9 (7–83) | Frequency (Hz) | 105.8 (±45.1) | Frequency (Hz) | 108.1 (±45.5) |
| Sex (M/F) | 21:18 | Pulse width (μs) | 216.9 (±99.4) | Pulse width (μs) | 219.8 (±110.9) |
| Age of onset (yr) | 31.1 (2–65) | Voltage (V) | 2.9 (±0.7) | Voltage (V) | 2.8 (±0.6) |
| Disease duration before DBS (yr) | 14.3 (±14.0) | Impedance (Ω; n = 35) | 1066.6 (±355.0) | Impedance (Ω; n = 35) | 1129.5 (±532.6) |
| Follow-up period after DBS (mo) | 13.4 (±6.6) | No. (%) leads in bipolar modea | 17 (43.6%) | No. (%) leads in bipolar modea | 19 (48.7%) |
| Positive for DYT1 mutation | 9 | ||||
| Baseline UDRS | 33 (±23.3) | ||||
| Postoperative UDRS | 14.6 (±15) | ||||
| UDRS improvement (%) | 53.2% (±34.5%) | ||||
| Nonresponders (No.) (%) ≤25% improvement | 7 (17.9%) | ||||
a
Patients programmed with bilateral bipolar configuration (n = 13).